ARIAD Pharma (ARIA) lower after Bernie Sanders sends letter on pricing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/19/2024
- Stocks sink, oil jumps after Israeli attack on Iran
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Oil surges as reports of Israeli strike on Iran roil markets
- Reports of Israeli attack on Iran spark rush to yen, Swiss franc
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Netflix (NFLX) Tops Q1 EPS by 77c, Offers Guidance
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
JPMorgan Downgrades ARIAD Pharmaceuticals (ARIA) to Underweight
October 24, 2016 6:37 AM EDT(Updated - October 24, 2016 10:00 AM EDT)
JPMorgan downgraded ARIAD Pharmaceuticals (NASDAQ: ARIA) from Neutral to Underweight with a price target of $7.00. Analyst Anupam Rama anticipates more volatility, as concerns about valuation are coupled with political headline risk related to Iclusig pricing.
"We do not expect to see resolution of these political / pricing headlines, nor clarity on the appropriate dose for Iclusig in the near term. As... More
ARIAD Pharma (ARIA) Shares Drop to Session Lows
October 21, 2016 2:24 PM EDTARIAD Pharma (NASDAQ: ARIA) shares are slipping to session lows. The stock is down nearly 3 percent on today's session.
... MoreARIAD Pharma (ARIA) Acknowledges Receipt of Congressional Letter; Issues Commentary
October 20, 2016 4:22 PM EDTARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) acknowledged the receipt of a Congressional... More
